Stoke Therapeutics, Inc.
← Back to STOK Overview

Stoke Therapeutics, Inc. (STOK)

Solvency & Capital Structure

Total Debt

$3.4M

Net Debt

-$340.1M

Stoke Therapeutics, Inc. currently has $3.4M in total debt. Net debt is -$340.1M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.

Financial Fundamentals

STOKQuarterly Data • 5Y View

DateTotal Debt ($B)Cash & Inv. ($B)Net Debt ($B)Total AssetsDebt/Assets
2026-03-310.000.34-0.34Net Cash0.440.8%
2025-12-310.000.28-0.28Net Cash0.420.7%
2025-09-300.000.25-0.25Net Cash0.360.8%
2025-06-300.000.25-0.25Net Cash0.380.6%
2025-03-310.000.36-0.35Net Cash0.410.6%
2024-12-310.000.22-0.21Net Cash0.271.8%
2024-09-300.000.24-0.24Net Cash0.290.8%
2024-06-300.000.28-0.28Net Cash0.310.7%
2024-03-310.000.18-0.18Net Cash0.211.1%
2023-12-310.000.20-0.20Net Cash0.230.9%
2023-09-300.000.21-0.21Net Cash0.241.0%
2023-06-300.000.23-0.23Net Cash0.261.0%
2023-03-310.000.25-0.25Net Cash0.280.9%
2022-12-310.000.23-0.23Net Cash0.260.9%
2022-09-300.000.25-0.25Net Cash0.280.8%
2022-06-300.000.28-0.27Net Cash0.300.7%
2022-03-310.000.29-0.29Net Cash0.320.5%
2021-12-310.010.22-0.21Net Cash0.242.1%
2021-09-300.010.24-0.23Net Cash0.252.1%
2021-06-300.000.25-0.25Net Cash0.260.2%
2021-03-310.000.27-0.27Net Cash0.280.0%
2020-12-310.000.29-0.29Net Cash0.300.4%
2020-09-300.000.19-0.19Net Cash0.200.6%
2020-06-300.000.20-0.20Net Cash0.210.5%
2020-03-310.000.21-0.21Net Cash0.220.5%
2019-12-310.000.22-0.22Net Cash0.230.0%
2019-09-300.000.23-0.23Net Cash0.240.0%
2019-06-300.000.24-0.24Net Cash0.250.0%
2019-03-310.000.10-0.10Net Cash0.100.0%
2018-12-310.000.11-0.11Net Cash0.110.0%
2018-03-310.000.00-0.00Net Cash0.00